Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

• Status: Recruiting
• Trial end date: 2023-10-01

Summary

The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).

• Phase: Phase 2

Details

• Lead Sponsor: Centre Leon Berard
• Treatments: Aromatase Inhibitors; Exemestane; Letrozole